128 results on '"Minelli, Silvia"'
Search Results
2. Co-infections observed in SARS-CoV-2 positive patients using a rapid diagnostic test
3. Closing the Gap in Proteomic Identification of Histoplasma capsulatum: A Case Report and Review of Literature
4. Laboratory Automation in Microbiology: Impact on Turnaround Time of Microbiological Samples in COVID Time
5. Clinical outcome and correlates of coronary microvascular obstruction in latecomers after acute myocardial infarction
6. Instantaneous Wave-free Ratio versus Fractional Flow Reserve
7. Antimicrobial resistance in the times of COVID-19 in a roman teaching hospital
8. Ceftazidime/Avibactam-Resistant Klebsiella pneumoniae subsp. pneumoniae Isolates in a Tertiary Italian Hospital: Identification of a New Mutation of the Carbapenemase Type 3 (KPC-3) Gene Conferring Ceftazidime/Avibactam Resistance
9. A Complex Case of Angulated and Bifurcated Lesion Facilitated by Excimer Laser Coronary Angioplasty
10. New strategies for the management of no-reflow after primary percutaneous coronary intervention
11. Changes in renal function and occurrence of contrast-induced nephropathy after percutaneous coronary interventions in patients with atrial fibrillation treated with non-vitamin K oral anticoagulants or warfarin
12. An in-depth analysis of nosocomial bloodstream infections due to Gram-negative bacilli: clinical features, microbiological characteristics and predictors of mortality in a 1 year, prospective study in a large tertiary care Italian hospital
13. Emergence of KPC-producing Klebsiella pneumoniae in Italy
14. Characterization of coagulase-negative staphylococcal isolates from blood with reduced susceptibility to glycopeptides and therapeutic options
15. Acinetobacter baumannii in intensive care unit: A novel system to study clonal relationship among the isolates
16. Rapid and cost-effective identification and antimicrobial susceptibility testing in patients with Gram-negative bacteremia directly from blood-culture fluid
17. Analysis of the Current Clinical Research Management System of Investigator Initiated Trials in China
18. Microvascular obstruction is an independent predictor of major adverse cardiovascular events in latecomers after ST-elevation myocardial infarction
19. Temporal trends in adverse events after everolimus-eluting bioresorbable vascular scaffold versus everolimus-eluting metallic stent implantation: A meta-analysis of randomized controlled trials
20. Clinical outcome and correlates of coronary microvascular obstruction in latecomers after acute myocardial infarction
21. Microvascular obstruction is an independent predictor of major adverse cardiovascular events in latecomers after ST-elevation myocardial infarction
22. Temporal Trends in Adverse Events After Everolimus-Eluting Bioresorbable Vascular Scaffold Versus Everolimus-Eluting Metallic Stent Implantation
23. Microbiological Approach in Diagnosing Native and Heart Valves Prosthesis Infections
24. An in-depth analysis of nosocomial bloodstream infections due to Gram-negative bacilli: clinical features, microbiological characteristics and predictors of mortality in a 1 year, prospective study in a large tertiary care Italian hospital.
25. Coronary in-stent restenosis in patients treated with thoracic external beam radiation for cancer
26. Very late stent thrombosis complicating a previously lost and partially crushed stent: Demonstration by optical coherence tomography
27. Coronary In-Stent Restenosis in Patients Treated With Thoracic External Beam Radiation for Cancer
28. Corrigendum to “Permanent polymer of drug eluting stents increases eosinophil cationic protein levels following percutaneous coronary intervention independently of C-reactive protein” [Atherosclerosis 237 (2014) 816–820]
29. Permanent polymer of drug eluting stents increases eosinophil cationic protein levels following percutaneous coronary intervention independently of C-reactive protein
30. A meta-analysis of first-generation drug-eluting vs bare-metal stents for coronary chronic total occlusion: Effect of length of follow-up on clinical outcome
31. Microvascular obstruction after primary percutaneous coronary intervention: pathogenesis, diagnosis and prognostic significance
32. Eosinophil cationic protein and clinical outcome after bare metal stent implantation
33. Baseline C-Reactive Protein Serum Levels and In-Stent Restenosis Pattern After m-TOR Inhibitors Drug-Eluting Stent Implantation
34. Microvascular Obstruction After Primary Percutaneous Coronary Intervention: Pathogenesis, Diagnosis and Prognostic Significance
35. Excimer laser coronary angioplasty with manual thrombus aspiration for a case of very late stent thrombosis of sirolimus-eluting stent
36. Angiographic patterns of myocardial reperfusion after primary angioplasty and ventricular remodeling
37. SERUM LEVELS OF GAMMA-GLUTAMYL TRANSFERASE PREDICT CORONARY ATHEROSCLEROSIS PROGRESSION IN PATIENTS WITH ISCHEMIC HEART DISEASE UNDER OPTIMAL MEDICAL THERAPY
38. Eosinophil cationic protein and clinical outcome after bare metal stent implantation
39. Infectious caused by community-acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA): three-years experience of an universitary hospital in Rome
40. Emergence of KPC-producing Klebsiella pneumoniae in Italy
41. Klebsiella pneumoniae KPC: first isolations in Italy
42. Acinetobacter baumannii in intensive care unit: A novel system to study clonal relationship among the isolates
43. Performance of Strand Displacement Amplification Assay in the Detection of Chlamydia trachomatis and Neisseria gonorrhoeae
44. New Site of Modification of 23S rRNA Associated with Clarithromycin Resistance of Helicobacter pylori Clinical Isolates
45. Emergence of KPC-producing Klebsiellapneumoniae in Italy.
46. New Site of Modification of 23S rRNA Associated with Clarithromycin Resistance of Helicobacter pyloriClinical Isolates
47. Baseline C-reactive protein serum levels and in-stent restenosis pattern after m-TOR inhibitors drug-eluting stent implantation
48. Changes in renal function and occurrence of contrast-induced nephropathy after percutaneous coronary interventions in patients with atrial fibrillation treated with non-vitamin K oral anticoagulants or warfarin.
49. [Clinical value of inflammatory biomarkers after stent implantation].
50. [Myocardial no-reflow phenomenon: recent knowledges].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.